Antibiotic resistance profiles and associated factors of Pseudomonas Infections among patients admitted to large tertiary care hospital from a developing country [PDF]
Antimicrobial Resistance and Infection Control, 2023 Background Pseudomonas infections are among the most common infections encountered in hospitalized patients, especially those with chronic illnesses or an immunocompromised state.
Sara Shbaita +7 more
doaj +3 more sources
How to manage Pseudomonas aeruginosa infections
Drugs in Context, 2018 Infections with Pseudomonas aeruginosa have become a real concern in hospital-acquired infections, especially in critically ill and immunocompromised patients.
Matteo Bassetti +4 more
doaj +2 more sources
A proposed integrated approach for the preclinical evaluation of phage therapy in Pseudomonas infections. [PDF]
Sci Rep, 2016 Bacteriophage therapy is currently resurging as a potential complement/alternative to antibiotic treatment. However, preclinical evaluation lacks streamlined approaches.
Danis-Wlodarczyk K +13 more
europepmc +2 more sources
Immune Responses to Pseudomonas aeruginosa Biofilm Infections
Frontiers in Immunology, 2021 Pseudomonas aeruginosa is a key pathogen of chronic infections in the lungs of cystic fibrosis patients and in patients suffering from chronic wounds of diverse etiology. In these infections the bacteria congregate in biofilms and cannot be eradicated by
Claus Moser +8 more
doaj +2 more sources
Epidemiology and risk factors of extensively drug-resistant Pseudomonas aeruginosa infections. [PDF]
PLoS ONE, 2018 The incidence of nosocomial infections from extensively drug-resistant Pseudomonas aeruginosa (XDR-PA) has been increasing worldwide. We investigated the prevalence and factors associated with XDR-PA infections, including the factors that predict ...
Nattawan Palavutitotai +4 more
doaj +2 more sources
Clinical Manifestations and Experience of Diagnosis and Treatment of Lymphoid Tissue Infection Caused by Pseudomonas Aeruginosa [PDF]
Zhongguo quanke yixue, 2023 Pseudomonas aeruginosa is a conditional pathogen, which is a common pathogen in nosocomial infections and relatively rare in community infections. At present, there are few reports on the clinical manifestations of Pseudomonas aeruginosa infection ...
LI Yafeng
doaj +1 more source
Pseudomonas aeruginosa: Infections, Animal Modeling, and Therapeutics
Cells, 2023 Pseudomonas aeruginosa is an important Gram-negative opportunistic pathogen which causes many severe acute and chronic infections with high morbidity, and mortality rates as high as 40%. What makes P. aeruginosa a particularly challenging pathogen is its
Stephen J Wood, T. Kuzel, S. Shafikhani
semanticscholar +1 more source
The Epidemiology and Pathogenesis and Treatment of Pseudomonas aeruginosa Infections: An Update
Drugs, 2021 Pseudomonas aeruginosa is a Gram-negative bacterial pathogen that is a common cause of nosocomial infections, particularly pneumonia, infection in immunocompromised hosts, and in those with structural lung disease such as cystic fibrosis. Epidemiological
D. Reynolds, M. Kollef
semanticscholar +1 more source
Pseudomonas aeruginosa Infections in Cancer Patients
Pathogens, 2022 Pseudomonas aeruginosa (P. aeruginosa) is one of the most frequent opportunistic microorganisms causing infections in oncological patients, especially those with neutropenia.
Paulina Paprocka +5 more
semanticscholar +1 more source
Ecthyma gangrenosum in a patient with non-Hodgkin lymphoma [PDF]
Vojnosanitetski Pregled, 2007 Introduction. Ecthyma gangrenosum is a rare disease of the skin that causes the localized necrosis of the skin and subcutaneous fat tissue, leading to the multiple ulcerations surrounded by local hyperaemia.
Čolović Nataša +3 more
doaj +1 more source